Cambridge Cognition Holdings plc is a United Kingdom-based company, which is engaged in developing and marketing digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB, Electronic Clinical Outcomes Assessment (eCOA), NeuroVocalix, Winterlight, Cognition Kit, Clinpal, eConsent, and AQUA. CANTAB Connect gives the control to manage and deliver battery of touchscreen and voice assessments, as well as fully customizable electronic questionnaires and scales. The Companyâs therapeutic areas include attention deficit hyperactivity disorder (ADHD), Alzheimerâs Disease, Autism Spectrum Disorder, Cognitive Safety, Core Cognitive Function, Depression, Downâs Syndrome, Drug Abuse Liability, Epilepsy, Huntingtonâs Disease, Multiple Sclerosis, Neuromuscular Disorders, Obsessive Compulsive Disorder, Parkinsonâs Disease, Schizophrenia, Stroke and Cerebrovascular Disease, and Traumatic Brain Injury.
More about the company